Can walking together help cancer patients and caregivers? new study says maybe.
NCT ID NCT06073951
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study tested a program called Mates in Motion, which helps blood cancer patients and their caregiving partners support each other to be more physically active. 96 couples participated, with patients who had a stem cell transplant or CAR-T therapy. The program included walking goals, activity trackers, and communication training. The goal was to see if the program was feasible and acceptable, and if it could improve physical endurance and health.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- couple-based physical activity program
- What this could lead to
- If it works, this could point toward a way to improve physical health and endurance for both patients and their caregiving partners after cancer treatment.
- What could go wrong
- This is a small feasibility study, not a large trial. It only tests if the program is acceptable and doable, not whether it actually improves health outcomes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
96 people
The number who actually took part.
- Started
-
Mar 2024
- Finished
-
Sep 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * PATIENTS: Age 18 years or older * PATIENTS: Scheduled to receive an autologous or allogeneic hematopoietic cell transplant (HCT) or chimeric antigen receptor (CAR)-T cell therapy * PATIENTS: Able to speak and comprehend English * PATIENTS: Being married or in a committed (self-defined) cohabiting same- or opposite-sex relationship * PATIENTS: Physician-approved for a walking program * CAREGIVERS: Age 18 years or older * CAREGIVERS: Able to speak and comprehend English * CAREGIVERS: Married to or in a committed, cohabiting, same- or opposite-sex relationship with the patient * CAREGIVERS: Able to participate in a walking program Exclusion Criteria: * None per se beyond the converse of the inclusions listed above, for example, age younger than 18 years and non-partnered
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Hematopoietic and lymphoid system neoplasm are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Mayo Clinic in Arizona
Scottsdale, Arizona, 85259, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a vaccine stop GI cancers from returning?
- Can a phone app help childhood cancer survivors keep track of their health?
- Can the way we word cancer research invitations boost participation?
- A chill pill for Chemo's side effects? cooling therapy and a Blood-Flow drug take on nerve pain
- Wearable tech could spot Post-Surgery problems early
- Can an AI chatbot ease the aftermath of cancer?